Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
Calafat M, Mañosa M, Ricart E, Nos P, Iglesias-Flores E, Vera I, López-Sanromán A, Guardiola J, Taxonera C, Mínguez M, Martín-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, García-López S, Márquez L, Gomollón F, Barrio J, Esteve M, Muñoz F, Gisbert JP, Gutiérrez A, Hinojosa J, Argüelles-Arias F, Busquets D, Bujanda L, Pérez-Calle JL, Sicilia B, Merino O, Martínez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodríguez C, Fe García-Sepulcre M, Monfort D, Cañete F, Domènech E; ENEIDA Study Group of GETECCU. Calafat M, et al. J Crohns Colitis. 2022 Jul 14;16(6):946-953. doi: 10.1093/ecco-jcc/jjab213. J Crohns Colitis. 2022. PMID: 34864947
Is safety infliximb during pregnancy in patients with inflammatory bowel disease?
Argüelles-Arias F, Castro-Laria L, Barreiro-de Acosta M, García-Sánchez MV, Guerrero-Jiménez P, Gómez-García MR, Cordero-Ruiz P, Iglesias-Flores E, Gómez-Camacho F, Domínguez-Muñoz EJ, Herrerías-Gutiérrez JM. Argüelles-Arias F, et al. Rev Esp Enferm Dig. 2012 Feb;104(2):59-64. doi: 10.4321/s1130-01082012000200003. Rev Esp Enferm Dig. 2012. PMID: 22372798 Free article.
Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease.
Argüelles-Arias F, Barreiro-de-Acosta M, Carballo F, Hinojosa J, Tejerina T. Argüelles-Arias F, et al. Rev Esp Enferm Dig. 2013 Jan;105(1):37-43. doi: 10.4321/s1130-01082013000100006. Rev Esp Enferm Dig. 2013. PMID: 23548008 Free article.
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Soto-Escribano P, Calvo-Moya M, Ginard-Vicens D, Chaparro-Sánchez M, Hernández-Durán M, Castro-Senosiain B, Fernández-Villaverde A, García-Sánchez V, Domínguez-Muñoz E, Caunedo-Álvarez A, Herrerías-Gutiérrez JM. Argüelles-Arias F, et al. Dig Dis Sci. 2013 Oct;58(10):2949-54. doi: 10.1007/s10620-013-2762-2. Epub 2013 Jul 5. Dig Dis Sci. 2013. PMID: 23828140
Author´s answer: Biosimilar therapy for inflammatory bowel disease.
Argüelles-Arias F, Barreiro-de-Acosta M, Carballo F, Hinojosa J, Tejerina T. Argüelles-Arias F, et al. Rev Esp Enferm Dig. 2014 Jan;106(1):67-8. doi: 10.4321/s1130-01082014000100015. Rev Esp Enferm Dig. 2014. PMID: 24689723 Free article. No abstract available.
New contributions to consensus on biosimilars.
Argüelles-Arias F, Barreiro-de-Acosta M, Carballo F, Hinojosa J, Tejerina T. Argüelles-Arias F, et al. Rev Esp Enferm Dig. 2014 Mar;106(3):228-9. Rev Esp Enferm Dig. 2014. PMID: 25007024 Free article. No abstract available.
113 results